Skip To Main Content
Jordan C. Barone on Muck Rack

Jordan C. Barone

As seen in: Nature, Economic Policy Review (Federal Reserve Bank of New York), The Journal of Clinical Psychiatry, Biological Psychiatry
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Jordan C.

Contact Jordan C., search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Peripheral cyclical expression of GABA-A receptor subunit genes and menstrual cycle affective change: a dimensional, transdiagnostic study - Translational Psychiatry

|
By Jordan C. Barone, Raffaele Romano, Anisha Nagpal, Antonio Salerno, Anna Patterson, Elizabeth Wenzel, Graziano Pinna
| Nature Verified
Abstract Menstrual cycle affective change (MCAC), including conditions like Premenstrual Dysphoric Disorder (PMDD), is triggered by ovarian hormone fluctuations, but its neurobiological mechanisms remain poorly understood. A leading hypothesis implicates abnormal GABA-A receptor (GABAAR) subunit regulation in altering sensitivity to neuroactive steroids, a theory difficult to test in humans.
Open in Who Shared Issue with article?

Biomarker development for menstrual cycle affective change: the need for greater temporal, mechanistic, and phenotypic specificity - Neuropsychopharmacology

|
By Jordan C. Barone, Tory Eisenlohr-Moul
| Nature Verified
Approximately 6% of ovulating individuals experience the debilitating affective symptoms of Premenstrual Dysphoric Disorder (PMDD), which arise premenstrually and remit post-menses [1]. Meanwhile, nearly 60% of female patients with depression experience cyclical worsening similar to PMDD but without full post-menstrual remission, termed Perimenstrual Exacerbation (PME) [2].
Open in Who Shared Issue with article?

GnRH Analogs in Premenstrual Dysphoric Disorder: Review and Practical Guideline

|
By Melissa Wagner-Schuman, Alyssa Kania, Jordan C. Barone, Jaclyn M. Ross
| The Journal of Clinical Psychiatry Verified
ABSTRACT Objective: Despite the documented success of gonadotropin-releasing hormone analogs (GnRHa) for the treatment of treatment-resistant premenstrual dysphoric disorder (PMDD), many patients struggle to find providers who have sufficient knowledge of PMDD and its evidence-based treatments and/or who are comfortable treating PMDD after first-line treatment options have failed.
Open in Who Shared Issue with article?
See all 4 licensed articles (5 Total)